Dermodan

Dermodan may be available in the countries listed below.

Ingredient matches for Dermodan

Tretinoin

Tretinoin is reported as an ingredient of Dermodan in the following countries:

• Chile

International Drug Name Search

B-Vex D

Generic Name: brompheniramine and phenylephrine (BROM fen IR a meen and FEN il EFF rin)

Brand Names: Alacol, Alenaze-D, Alenaze-D NR, B-Vex D, BPM PE, Brom Tann PE, Bromfed, Bromfed-PD Capsules, BroveX ADT, BroveX PEB, Brovex-D, Children's Cold & Allergy, Dimaphen Elixir, Dimetapp Cold & Allergy, Entre-B, J-Tan D, J-Tan D SR, Phenyl 15/12mg, Phenyl 7.5/6mg, RespaHist II, Rhinabid, Rhinabid PD, Seradex-LA, Tanabid SR, V-Hist, VazoBid, VaZol-D, Vazotab, Zotex-PE

What is B-Vex D (brompheniramine and phenylephrine)?

Brompheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.

Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).

The combination of brompheniramine and phenylephrine is used to treat nasal congestion, sneezing, itching, watery eyes, and runny nose caused by allergies, hay fever, and the common cold.

Brompheniramine and phenylephrine may also be used for purposes not listed in this medication guide.

What is the most important information I should know about B-Vex D (brompheniramine and phenylephrine)?

Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. You should not use this medication if you are allergic to brompheniramine or phenylephrine, or to other decongestants, diet pills, stimulants, or ADHD medications. Do not use brompheniramine and phenylephrine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Ask a doctor or pharmacist about taking brompheniramine and phenylephrine if you have heart disease or high blood pressure, diabetes, a thyroid disorder, glaucoma, kidney disease, an enlarged prostate, or problems with urination.

What should I discuss with my healthcare provider before taking B-Vex D (brompheniramine and phenylephrine)?

You should not use this medication if you are allergic to brompheniramine or phenylephrine, or to other decongestants, diet pills, stimulants, or ADHD medications. Do not use brompheniramine and phenylephrine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Ask a doctor or pharmacist if it is safe for you to take brompheniramine and phenylephrine if you have:

• 
  

  heart disease or high blood pressure;

  
  


• 
  

  diabetes;

  
  


• 
  

  a thyroid disorder;

  
  


• 
  

  glaucoma;

  
  


• 
  

  kidney disease;

  
  


• 
  

  an enlarged prostate; or

  
  


• 
  

  problems with urination.

  
  

FDA pregnancy category C. It is not known whether brompheniramine and phenylephrine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Brompheniramine and phenylephrine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take B-Vex D (brompheniramine and phenylephrine)?

Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cough or cold medicine is usually taken only for a short time until your symptoms clear up.

Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Take the medicine with a full glass of water. Do not crush, chew, break, or open an extended-release capsule. Swallow it whole. Breaking or opening the pill may cause too much of the drug to be released at one time.

The chewable tablet must be chewed before you swallow it.

Measure liquid medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

Shake the oral suspension (liquid) well just before you measure a dose. Do not take brompheniramine and phenylephrine for longer than 7 days in a row. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash. Store at room temperature away from moisture and heat.

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include feeling restless or nervous, nausea, vomiting, stomach pain, dizziness, drowsiness, dry mouth, warmth or tingly feeling, or seizure (convulsions).

What should I avoid while taking B-Vex D (brompheniramine and phenylephrine)?

This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Avoid becoming overheated or dehydrated during exercise and in hot weather.

Drinking alcohol can increase certain side effects of brompheniramine and phenylephrine. Ask a doctor or pharmacist before using any other cold, cough, allergy, or pain medicine. Antihistamines and decongestants are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine or decongestant.

Avoid taking this medication if you also take diet pills, caffeine pills, or other stimulants (such as ADHD medications). Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.

B-Vex D (brompheniramine and phenylephrine) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have a serious side effect such as:

• 
  

  fast, pounding, or uneven heartbeat;

  
  


• 
  

  severe dizziness, anxiety, restless feeling, or nervousness;

  
  


• 
  

  easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms;

  
  


• 
  

  nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or

  
  


• 
  

  dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure).

  
  

Less serious side effects may include:

• 
  

  drowsiness or dizziness;

  
  


• 
  

  blurred vision;

  
  


• 
  

  dry mouth, nose, or throat;

  
  


• 
  

  mild stomach pain, constipation;

  
  


• 
  

  problems with memory or concentration;

  
  


• 
  

  feeling restless or excited (especially in children);

  
  


• 
  

  sleep problems (insomnia); or

  
  


• 
  

  warmth, redness, or tingly feeling under your skin.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect B-Vex D (brompheniramine and phenylephrine)?

Before using brompheniramine and phenylephrine, tell your doctor if you regularly use other medicines that make you sleepy (such as cold or allergy medicine, sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). They can add to sleepiness caused by brompheniramine and phenylephrine.

Tell your doctor about all other medications you are using, especially:

• 
  

  medicines to treat high blood pressure;

  
  


• 
  

  a beta blocker such as atenolol (Tenormin, Tenoretic), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Dutoprol, Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others; or

  
  


• 
  

  antidepressants such as amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Janimine, Tofranil), and others.

  
  

This list is not complete and other drugs may interact with brompheniramine and phenylephrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More B-Vex D resources

• B-Vex D Side Effects (in more detail)
• B-Vex D Use in Pregnancy & Breastfeeding
• B-Vex D Drug Interactions
• B-Vex D Support Group
• 0 Reviews for B-Vex D - Add your own review/rating

• Alenaze-D Elixir MedFacts Consumer Leaflet (Wolters Kluwer)


• Bromfed MedFacts Consumer Leaflet (Wolters Kluwer)


• BroveX-D Suspension MedFacts Consumer Leaflet (Wolters Kluwer)


• Entre-B Prescribing Information (FDA)


• J-Tan D Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• Rhinabid Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

Compare B-Vex D with other medications

• Hay Fever
• Nasal Congestion
• Rhinitis

Where can I get more information?

• Your pharmacist can provide more information about brompheniramine and phenylephrine.

See also: B-Vex D side effects (in more detail)

Etoposido World Pharma

Etoposido World Pharma may be available in the countries listed below.

Ingredient matches for Etoposido World Pharma

Etoposide

Etoposide is reported as an ingredient of Etoposido World Pharma in the following countries:

• Peru

International Drug Name Search

Novales

Novales may be available in the countries listed below.

Ingredient matches for Novales

Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Novales in the following countries:

• Indonesia

International Drug Name Search

Budenobronch

Budenobronch may be available in the countries listed below.

Ingredient matches for Budenobronch

Budesonide

Budesonide is reported as an ingredient of Budenobronch in the following countries:

• Germany

International Drug Name Search

Valproat-CT

Valproat-CT may be available in the countries listed below.

Ingredient matches for Valproat-CT

Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valproat-CT in the following countries:

• Germany

International Drug Name Search

Endometrin

Endometrin is a brand name of progesterone, approved by the FDA in the following formulation(s):

ENDOMETRIN (progesterone - insert; vaginal)

• 
  Manufacturer: FERRING
  
  Approval date: June 21, 2007
  
  Strength(s): 100MG ^[RLD]

Has a generic version of Endometrin been approved?

No. There is currently no therapeutically equivalent version of Endometrin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Endometrin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Vaginally administrable progesterone-containing tablets and method for preparing same
  Patent 7,300,664
  Issued: November 27, 2007
  Inventor(s): Jossifoff; Azariah
  Assignee(s): Ferring B.V.
  There is provided a method for preparing a tablet for the vaginal administration of progesterone for systemic use, comprising the steps of: slowly mixing water with micronized progesterone, the total amount of water mixed with said micronized progesterone not exceeding the maximum wetting capacity of the micronized progesterone, whereby to obtain wetted micronized progesterone; drying said wetted, micronized progesterone to a humidity content of substantially 0%, whereby to form substantially dry micronized progesterone; mixing said substantially dry micronized progesterone with other pharmaceutically acceptable excipients or diluents therefor; and forming a tablet by direct compaction of said substantially dry micronized progesterone which has been mixed with said other pharmaceutically acceptable excipients or diluents therefor. Tablets so prepared, as well as a tablet comprising between about 6 to 20 wt. % progesterone and between about 5 to 12 wt. % effervescent, are also provided.
  
  Patent expiration dates:
  
  
  • November 17, 2019
    
    ✓ 
    Patent use: SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED REPORDUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN
  
  



• 
  Vaginally administrable progesterone-containing tablets and method for preparing same
  Patent 7,320,800
  Issued: January 22, 2008
  Inventor(s): Jossifoff; Azariah
  Assignee(s): Ferring B.V.
  The present invention provides a method for preparing a tablet for the vaginal administration of progesterone for systemic use. The method comprises first mixing water with micronized progesterone, the total amount of water mixed with said micronized progesterone not exceeding the maximum wetting capacity of the micronized progesterone, drying the wetted, micronized progesterone; mixing the dry micronized progesterone with other pharmaceutically acceptable excipients or diluents; and; forming a tablet by direct compaction of the dry micronized progesterone. Tablets prepared by this method are also provided.
  
  Patent expiration dates:
  
  
  • November 17, 2019
    
    ✓ 
    Patent use: SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED REPORDUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN
  
  



• 
  Vaginally administratable progesterone-containing tablets and method for preparing same
  Patent 7,393,543
  Issued: July 1, 2008
  Inventor(s): Jossifoff; Azariah
  Assignee(s): Ferring B.V.
  The present invention provides a method for preparing a tablet for the vaginal administration of progesterone for systemic use. The method comprises first mixing water with micronized progesterone, the total amount of water mixed with said micronized progesterone not exceeding the maximum wetting capacity of the micronized progesterone, drying the wetted, micronized progesterone; mixing the dry micronized progesterone with other pharmaceutically acceptable excipients or diluents; and; forming a tablet by direct compaction of the dry micronized progesterone. Tablets prepared by this method are also provided.
  
  Patent expiration dates:
  
  
  • November 17, 2019
    
    ✓ 
    Patent use: ENDOMETRIN IS A PROGESTERONE INDICATED TO SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN
    ✓ 
    Drug product
  
  

See also...

• Endometrin Consumer Information (Drugs.com)
• Endometrin Insert Consumer Information (Wolters Kluwer)
• Endometrin Consumer Information (Cerner Multum)
• Progesterone Consumer Information (Drugs.com)
• Progesterone Consumer Information (Wolters Kluwer)
• Progesterone Gel Consumer Information (Wolters Kluwer)
• Progesterone Insert Consumer Information (Wolters Kluwer)
• Progesterone Oil Consumer Information (Wolters Kluwer)
• FIRST-Progesterone VGS 100 Consumer Information (Cerner Multum)
• FIRST-Progesterone VGS 200 Consumer Information (Cerner Multum)
• FIRST-Progesterone VGS 25 Consumer Information (Cerner Multum)
• FIRST-Progesterone VGS 400 Consumer Information (Cerner Multum)
• FIRST-Progesterone VGS 50 Consumer Information (Cerner Multum)
• Progesterone Consumer Information (Cerner Multum)
• Progesterone vaginal Consumer Information (Cerner Multum)
• Progesterone AHFS DI Monographs (ASHP)

Aciclovir Best

Aciclovir Best may be available in the countries listed below.

Ingredient matches for Aciclovir Best

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Best in the following countries:

• Colombia

International Drug Name Search

Nebivolol AbZ

Nebivolol AbZ may be available in the countries listed below.

Ingredient matches for Nebivolol AbZ

Nebivolol

Nebivolol hydrochloride (a derivative of Nebivolol) is reported as an ingredient of Nebivolol AbZ in the following countries:

• Germany

International Drug Name Search

Sélégiline Merck

Sélégiline Merck may be available in the countries listed below.

Ingredient matches for Sélégiline Merck

Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Sélégiline Merck in the following countries:

• France

International Drug Name Search

Oradin

Oradin may be available in the countries listed below.

Ingredient matches for Oradin

Ketorolac

Ketorolac is reported as an ingredient of Oradin in the following countries:

• Bangladesh

Loratadine

Loratadine is reported as an ingredient of Oradin in the following countries:

• Bangladesh

International Drug Name Search

Antipres

Antipres may be available in the countries listed below.

Ingredient matches for Antipres

Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Antipres in the following countries:

• Poland

Sertraline

Sertraline is reported as an ingredient of Antipres in the following countries:

• Indonesia

International Drug Name Search

Aderan

Aderan may be available in the countries listed below.

Ingredient matches for Aderan

Sibutramine

Sibutramine hydrochloride monohydrate (a derivative of Sibutramine) is reported as an ingredient of Aderan in the following countries:

• Argentina

International Drug Name Search

Aulin

Aulin may be available in the countries listed below.

Ingredient matches for Aulin

Nimesulide

Nimesulide is reported as an ingredient of Aulin in the following countries:

• Bulgaria


• Chile


• Croatia (Hrvatska)


• Czech Republic


• Ecuador


• Ireland


• Italy


• Philippines


• Poland


• Portugal


• Romania


• Serbia


• Slovakia


• Slovenia


• Switzerland


• Venezuela

International Drug Name Search

NovoMix 70 Penfill

NovoMix 70 Penfill may be available in the countries listed below.

Ingredient matches for NovoMix 70 Penfill

Insulin Aspart

Insulin Aspart biphasic (a derivative of Insulin Aspart) is reported as an ingredient of NovoMix 70 Penfill in the following countries:

• Austria


• Belgium

International Drug Name Search

Isoacne

Isoacne may be available in the countries listed below.

Ingredient matches for Isoacne

Isotretinoin

Isotretinoin is reported as an ingredient of Isoacne in the following countries:

• Spain

International Drug Name Search